EDGAR MORENO: Open Payments
NPI 1003381583 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,258 in 113 payments from 24 companies in 2025. Trend: 2023 $249 · 2024 $2,046 · 2025 $4,258
Food & beverage: $2,811Travel & lodging: $1,349Education: $99
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 26 | $2,288 |
| Novo Nordisk Inc | 17 | $358 |
| Xeris Pharmaceuticals, Inc. | 9 | $258 |
| Amgen Inc. | 13 | $255 |
| Lilly USA, LLC | 10 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Astellas Pharma US Inc | 1 | $99 |
| Dexcom, Inc. | 4 | $89 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $81 |
| Ascensia Diabetes Care Us Inc. | 4 | $74 |
Products named: MINIMED 780G, Ozempic, RECORLEV, TEPEZZA, LEQVIO, MOUNJARO, Dexcom G6 Transmitter, Wegovy.
Industry payments across CA — which companies pay providers there.
